Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,703,681
-
Share change
-
-79,648
-
Total reported value
-
$19,263,000
-
Price per share
-
$11.22
-
Number of holders
-
15
-
Value change
-
-$1,464,743
-
Number of buys
-
8
-
Number of sells
-
11
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q1 2022
As of 31 Mar 2022,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,703,681 shares.
The largest 10 holders included
Roumell Asset Management, LLC, INVESTMENT MANAGEMENT OF VIRGINIA LLC, VILLERE ST DENIS J & CO LLC, ARK Investment Management LLC, BROWN ADVISORY INC, BENJAMIN F. EDWARDS & COMPANY, INC., FNY Investment Advisers, LLC, PNC Financial Services Group, Inc., UBS Group AG, and SIMPLEX TRADING, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.